Health · 1 views
CAAR T-cell therapy offers a more targeted route for neurological autoimmune diseases
Researchers at DZNE and Charité—Universitätsmedizin Berlin are working on a targeted therapy for neurological autoimmune diseases. So far, they have successfully tested their approach in mouse studies involving two such conditions.
Summary
Researchers at DZNE and Charité—Universitätsmedizin Berlin are working on a targeted therapy for neurological autoimmune diseases. So far, they have successfully tested their approach in mouse studies involving two such conditions. Their concept is based on deliberately modified immune cells, so-called CAAR T cells, designed to eliminate only the immune cells responsible for causing disease. The team led by Prof.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- Early changes in the tumor environment may explain why immunotherapy works for some patients but not othersContinue reading
- GLP-1 drugs linked to 11-fold higher regurgitation rate under anesthesiaContinue reading
- Binge eating may map onto widespread brain differences in bulimia nervosaContinue reading
- Diabetes prevention: Epigenetic changes may influence the benefits of a healthy dietContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow